The Massachusetts General Hospital Hemophilia and Thrombosis Treatment Center offers multidisciplinary medical care. View our specific programs below.
Mass Comprehensive Hemophilia Treatment Center
The Massachusetts General Hospital Hemophilia and Thrombosis Center offers comprehensive care for children and adults with bleeding disorders, including hemophilia A, hemophilia B, rare clotting factor deficiencies and von Willebrand disease. We also care for patients with platelet dysfunction and thrombocytopenia.
Our Hemophilia Treatment Center (HTC) operates within the Massachusetts General Hospital for Children and Mass General. The HTC provides comprehensive care to children, adolescents and adults with complex inherited or acquired thrombotic disorders, including deep venous thrombosis, pulmonary embolism and pediatric stroke and TPP.
Blood Factor Program
The Massachusetts General Hospital Blood Factor Program was established as a non-profit factor home delivery service in 2014. Revenue generated through our Blood Factor Pharmacy Program have played an important role in the growth of our HTC clinical staff, creating more opportunities to support our patients and expand our services to our community. We have partnered with New England Life Care as our preferred Blood Factor Contract Pharmacy.
Our Blood Factor Program allows our clinical staff the ability to ship blood factor products directly to our patient’s home, conveniently and effectively. This model enables our team to more oversight into getting our patients their medication. Our team handles all eligibility determinations, prior authorizations, deliveries, blood factor management, billing and can troubleshoot any issues patients may experience quickly.
The Hemophilia and Thrombosis Center offers comprehensive evaluations and individualized care to children and adults with bleedings disorders due to hemophilia A, hemophilia B, rare clotting factor deficiencies and von Willebrand disease.